Tasisulam

DRUG3 trials

Sponsors

Eli Lilly and Company

Conditions

Advanced CancerLymphomaMetastatic Melanoma

Phase 1

A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma

TerminatedNCT01185548

Eli Lilly and CompanyAdvanced Cancer, Lymphoma

Start: 2010-07-31End: 2010-12-31Updated: 2018-10-19

A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients

TerminatedNCT01209832

Eli Lilly and CompanyAdvanced Cancer

Start: 2010-09-30End: 2011-01-31Updated: 2019-03-18

Phase 2

A Study of Tasisulam in Treating Participants With Malignant Melanoma

CompletedNCT00383292

Eli Lilly and CompanyMetastatic Melanoma

Start: 2006-11-30End: 2015-07-31Updated: 2018-06-06

Related Papers

Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam.

2018-06-014 citations